Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cliavist Enhancement in Spine Diseases
NCT00372281Phase 3Unknown
- Sponsor
- Strasbourg University Hospital
- Start
- Mar 2007
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of ciprofloxacin + ornidazole in spinal infection (SI) and Degenerative spinal disease, sponsored by Strasbourg University Hospital. Primary endpoint: MRI Contrast Enhancement. Status: unknown.
02
Drugs
ciprofloxacin + ornidazole
03
Conditions
spinal infection (SI)Degenerative spinal disease
Beyond the preview
Go deeper on NCT00372281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00372281.